Tag
1 article tagged with "Life sciences"
October 2, 2026/5 min read
The quarter's acquisitions, licences and IPOs in biotech, pharma, medtech and contract manufacturing, and the deal structures that ran through them: contingent value rights, asset-only purchases and strategic investors in IPOs.
Intertwine Partners
Twine SaverQuarterly reviewLife sciencesMarkets
Topics
